Institute for Protein Innovation (IPI) unveils its new 12,000-square-foot laboratory and office facility at a ribbon cutting ceremony today
First Research Institution to Purchase Carterra’s High-Throughput Label-Free Biosensor to Support its Novel Antibody Discovery
Be the first Director of Development! The Institute for Protein Innovation is looking to hire it’s first Director of Development to join their Executive Team and work closely with the Board to lead their philanthropy effort. Development leaders with an entrepreneurial spirit this role is for you! Click here for more information about the position and how to apply.
Scientist Timothy Springer has founded or financed some of biotechnology’s highest-profile companies. But for his latest entrepreneurial endeavor he’s taking an unusual tack: forming a nonprofit.
In an interview with Drug Discovery & Development, Springer explains what inspired the creation of the Institute for Protein Innovation and his vision for it going forward.
Timothy Springer, Ph.D., a professor at Harvard Medical School and Boston Children’s Hospital, has always been interested in developing antibodies targeting proteins that are “extracellular”—meaning they reside in bodily fluids, outside of cell walls. But he found that the amount of funding provided to academicians who are studying such proteins was lacking. So he decided to create his own funding mechanism, the Institute for Protein Innovation (IPI), which launched in Boston today.
While genomics unveiled a wealth of information, including the identity of genes that lead to disease when mutated, researchers still do not fully understand what all the genes really do and how mutations change their function and cause disease.Now proteins are promising to provide the missing link.
Poster presented at The Protein Engineering Summit - PEGS2017 - Boston, MA May 1–5, 2017.